R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study-Reference-Cited by-同舟云学术

R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study

Published:2020-09-11 Issue:10 Volume:111 Page:3770-3779
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kagami Yoshitoyo¹²^ORCID,Yamamoto Kazuhito²^ORCID,Shibata Taro³,Tobinai Kensei⁴,Imaizumi Yoshitaka⁵^ORCID,Uchida Toshiki⁶,Shimada Kazuyuki⁷^ORCID,Minauchi Koichiro⁸,Fukuhara Noriko⁹,Kobayashi Hirofumi¹⁰,Yamauchi Nobuhiko¹¹,Tsujimura Hideki¹²,Hangaishi Akira¹³,Tominaga Ryo¹⁴,Suehiro Youko¹⁵,Yoshida Shinichiro¹⁶,Inoue Yoshiko¹⁷,Suzuki Sachiko¹⁸,Tokuhira Michihide¹⁹^ORCID,Kusumoto Shigeru²⁰,Kuroda Junya²¹,Yakushijin Yoshihiro²²^ORCID,Takamatsu Yasushi²³,Kubota Yasushi²⁴,Nosaka Kisato²⁵^ORCID,Morishima Satoko²⁶^ORCID,Nakamura Shigeo²⁷,Ogura Michinori⁶,Maruyama Dai⁴^ORCID,Hotta Tomomitsu²⁸,Morishima Yasuo²,Tsukasaki Kunihiro²⁹,Nagai Hirokazu³⁰

Affiliation:

1. Department of Hematology Toyota Kosei Hospital Toyota Japan

2. Hematology and Cell Therapy Aichi Cancer Center Nagoya Japan

3. JCOG Data Center/Operations Office National Cancer Center Tokyo Japan

4. Department of Hematology National Cancer Center Hospital Tokyo Japan

5. Department of Hematology Nagasaki University Hospital Nagasaki Japan

6. Department of Hematology and Oncology Japanese Red Cross Nagoya Daini Hospital Nagoya Japan

7. Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya Japan

8. Department of Hematology Sapporo Hokuyu Hospital Sapporo Japan

9. Hematology and Rheumatology Tohoku University Hospital Sendai Japan

10. Department of Hematology Saitama Cancer Center Ina‐cho Japan

11. Department of Hematology National Cancer Center East Kashiwa Japan

12. Division of Hematology‐Oncology Chiba Cancer Center Chiba Japan

13. Division of Hematology NTT Medical Center Tokyo Tokyo Japan

14. Division of Hematology Hyogo Cancer Center Akashi Japan

15. Department of Hematology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

16. Department of Hematology National Hospital Organization Nagasaki Medical Center Ohmura Japan

17. Department of Hematology National Hospital Organization Kumamoto Medical Center Kumamoto Japan

18. Hematology National Hospital Organization Hokkaido Cancer Center Sapporo Japan

19. Departments of Hematology Saitama Medical Center Saitama Medical University Kawagoe Japan

20. Department of Hematology and Oncology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

21. Division of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan

22. First Department of Internal Medicine Ehime University Hospital Toon Japan

23. Division of Medical Oncology, Hematology and Infectious Diseases Department of Internal Medicine Fukuoka University Hospital Fukuoka Japan

24. Division of Hematology, Respiratory Medicine and Oncology Department of Internal Medicine Faculty of Medicine Saga University Saga Japan

25. Department of Hematology Kumamoto University Hospital Kumamoto Japan

26. Second Department of Internal Medicine University of the Ryukyus Hospital Nishihara Japan

27. Department of Pathology and Laboratory Medicine Nagoya University Hospital Nagoya Japan

28. National Hospital Organization Nagoya Medical Center Nagoya Japan

29. Department of Hematology International Medical Center Saitama Medical University Hidaka Japan

30. Department of Hematology National Hospital Organization Nagoya Medical Center Nagoya Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14604

Reference27 articles.

1. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

2. Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

3. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

4. Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

5. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brentuximab vedotin plus AVD followed by involved-node radiotherapy in a patient with classic Hodgkin lymphoma following gray zone lymphoma after autologous stem-cell transplantation failure;Hematology;2023-05-15

2. Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial;Japanese Journal of Clinical Oncology;2022-03-30